Physician profile
Daniel Adam Lyons
NPI 1346686722
$338.88
in general payments reported to CMS, 2019-2025
10 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.26 · 2021: $47.88 · 2022: $80.97 · 2024: $41.70 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $86.06 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Sientra, INC. | $72.76 | 2021-2022 | |
| Kerecis Limited | $41.12 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Allergan, INC. | $28.63 | 2020-2022 | |
| Acera Surgical, INC. | $27.31 | 2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $18.37 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Motiva USA, LLC | $17.46 | 2025 | |
| Coopersurgical, INC. | $16.50 | 2025 | Insorb |
| Ethicon US, LLC | $16.16 | 2025 | Ethicon, Stratafix, Vistaseal |
| Tela Bio, INC. | $14.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.